PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ABBV vs. ADI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ABBV and ADI is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

ABBV vs. ADI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AbbVie Inc. (ABBV) and Analog Devices, Inc. (ADI). The values are adjusted to include any dividend payments, if applicable.

-15.00%-10.00%-5.00%0.00%5.00%10.00%15.00%20.00%AugustSeptemberOctoberNovemberDecember2025
1.44%
-3.04%
ABBV
ADI

Key characteristics

Sharpe Ratio

ABBV:

0.40

ADI:

0.58

Sortino Ratio

ABBV:

0.65

ADI:

1.03

Omega Ratio

ABBV:

1.10

ADI:

1.12

Calmar Ratio

ABBV:

0.50

ADI:

1.06

Martin Ratio

ABBV:

1.23

ADI:

2.63

Ulcer Index

ABBV:

7.78%

ADI:

7.07%

Daily Std Dev

ABBV:

23.83%

ADI:

31.75%

Max Drawdown

ABBV:

-45.09%

ADI:

-82.88%

Current Drawdown

ABBV:

-14.53%

ADI:

-8.22%

Fundamentals

Market Cap

ABBV:

$303.17B

ADI:

$108.77B

EPS

ABBV:

$2.87

ADI:

$3.35

PE Ratio

ABBV:

59.78

ADI:

65.42

PEG Ratio

ABBV:

0.41

ADI:

1.01

Total Revenue (TTM)

ABBV:

$41.23B

ADI:

$9.43B

Gross Profit (TTM)

ABBV:

$30.76B

ADI:

$5.00B

EBITDA (TTM)

ABBV:

$17.62B

ADI:

$4.19B

Returns By Period

In the year-to-date period, ABBV achieves a -1.95% return, which is significantly lower than ADI's 4.23% return. Over the past 10 years, ABBV has underperformed ADI with an annualized return of 15.45%, while ADI has yielded a comparatively higher 17.53% annualized return.


ABBV

YTD

-1.95%

1M

-0.76%

6M

1.44%

1Y

8.17%

5Y*

20.19%

10Y*

15.45%

ADI

YTD

4.23%

1M

4.57%

6M

-3.04%

1Y

14.17%

5Y*

15.03%

10Y*

17.53%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ABBV vs. ADI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABBV
The Risk-Adjusted Performance Rank of ABBV is 5858
Overall Rank
The Sharpe Ratio Rank of ABBV is 6161
Sharpe Ratio Rank
The Sortino Ratio Rank of ABBV is 5050
Sortino Ratio Rank
The Omega Ratio Rank of ABBV is 5353
Omega Ratio Rank
The Calmar Ratio Rank of ABBV is 6767
Calmar Ratio Rank
The Martin Ratio Rank of ABBV is 6060
Martin Ratio Rank

ADI
The Risk-Adjusted Performance Rank of ADI is 6666
Overall Rank
The Sharpe Ratio Rank of ADI is 6666
Sharpe Ratio Rank
The Sortino Ratio Rank of ADI is 6060
Sortino Ratio Rank
The Omega Ratio Rank of ADI is 5757
Omega Ratio Rank
The Calmar Ratio Rank of ADI is 8080
Calmar Ratio Rank
The Martin Ratio Rank of ADI is 7070
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ABBV vs. ADI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and Analog Devices, Inc. (ADI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ABBV, currently valued at 0.40, compared to the broader market-2.000.002.004.000.400.58
The chart of Sortino ratio for ABBV, currently valued at 0.65, compared to the broader market-4.00-2.000.002.004.006.000.651.03
The chart of Omega ratio for ABBV, currently valued at 1.10, compared to the broader market0.501.001.502.001.101.12
The chart of Calmar ratio for ABBV, currently valued at 0.50, compared to the broader market0.002.004.006.000.501.06
The chart of Martin ratio for ABBV, currently valued at 1.23, compared to the broader market-10.000.0010.0020.0030.001.232.63
ABBV
ADI

The current ABBV Sharpe Ratio is 0.40, which is lower than the ADI Sharpe Ratio of 0.58. The chart below compares the historical Sharpe Ratios of ABBV and ADI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.501.001.502.002.50AugustSeptemberOctoberNovemberDecember2025
0.40
0.58
ABBV
ADI

Dividends

ABBV vs. ADI - Dividend Comparison

ABBV's dividend yield for the trailing twelve months is around 3.64%, more than ADI's 1.66% yield.


TTM20242023202220212020201920182017201620152014
ABBV
AbbVie Inc.
3.64%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%
ADI
Analog Devices, Inc.
1.66%1.73%1.73%1.85%1.57%1.68%1.82%2.24%2.02%2.31%2.89%2.67%

Drawdowns

ABBV vs. ADI - Drawdown Comparison

The maximum ABBV drawdown since its inception was -45.09%, smaller than the maximum ADI drawdown of -82.88%. Use the drawdown chart below to compare losses from any high point for ABBV and ADI. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-14.53%
-8.22%
ABBV
ADI

Volatility

ABBV vs. ADI - Volatility Comparison

The current volatility for AbbVie Inc. (ABBV) is 5.35%, while Analog Devices, Inc. (ADI) has a volatility of 7.60%. This indicates that ABBV experiences smaller price fluctuations and is considered to be less risky than ADI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%AugustSeptemberOctoberNovemberDecember2025
5.35%
7.60%
ABBV
ADI

Financials

ABBV vs. ADI - Financials Comparison

This section allows you to compare key financial metrics between AbbVie Inc. and Analog Devices, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab